Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 309 articles:
HTML format



Single Articles


    September 2022
  1. HESS CN, Bonaca MP
    Risk of remnants and remnant risk in peripheral artery disease.
    Eur Heart J. 2022;43:3270-3272.
    PubMed    


  2. MARQUINA C, Lacaze P, Tiller J, Riaz M, et al
    Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis.
    Eur Heart J. 2022;43:3243-3254.
    PubMed     Abstract available


  3. VERGALLO R, Pedicino D
    Which mechanical circulatory support device in acute myocardial infarction complicated by cardiogenic shock?
    Eur Heart J. 2022 Sep 6. pii: 6692466. doi: 10.1093.
    PubMed    


  4. CREA F
    Non-invasive diagnosis, antithrombotic treatment, and invasive management of ischaemic heart disease.
    Eur Heart J. 2022;43:3087-3091.
    PubMed    


  5. NADARAJAH R, Wu J, Hurdus B, Asma S, et al
    The collateral damage of COVID-19 to cardiovascular services: a meta-analysis.
    Eur Heart J. 2022;43:3164-3178.
    PubMed     Abstract available


  6. SPIRITO A, Cao D, Mehran R
    Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moon.
    Eur Heart J. 2022;43:3145-3147.
    PubMed    


  7. LANCELLOTTI P, Go YY, Nchimi A
    Stress imaging versus fractional flow reserve: what comes first-the chicken or the egg?
    Eur Heart J. 2022;43:3129-3131.
    PubMed    


  8. DRIESSEN RS, van Diemen PA, Raijmakers PG, Knuuti J, et al
    Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study.
    Eur Heart J. 2022;43:3118-3128.
    PubMed     Abstract available


  9. KITE TA, Kurmani SA, Bountziouka V, Cooper NJ, et al
    Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2022;43:3148-3161.
    PubMed     Abstract available


  10. GUEDENEY P, Thiele H, Collet JP
    Timing of invasive management of NSTE-ACS: is the time up for early management?
    Eur Heart J. 2022;43:3161-3163.
    PubMed    


    August 2022
  11. VON LEWINSKI D, Kolesnik E, Tripolt NJ, Pferschy PN, et al
    Empagliflozin in acute Myocardial Infarction: the EMMY trial.
    Eur Heart J. 2022 Aug 29. pii: 6677315. doi: 10.1093.
    PubMed     Abstract available


  12. GIDDING SS, Colangelo LA, Nwabuo CC, Lewis CE, et al
    PDAY risk score predicts cardiovascular events in young adults: the CARDIA study.
    Eur Heart J. 2022;43:2892-2900.
    PubMed     Abstract available


    July 2022
  13. DOLEJSI T, Delgobo M, Schuetz T, Tortola L, et al
    Adult T-cells impair neonatal cardiac regeneration.
    Eur Heart J. 2022;43:2698-2709.
    PubMed     Abstract available



  14. Corrigendum to: Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry.
    Eur Heart J. 2022 Jul 6. pii: 6632321. doi: 10.1093.
    PubMed    


  15. GAUDINO M, Farkouh ME, Stone GW
    Left main revascularization: an evidence-based reconciliation.
    Eur Heart J. 2022;43:2421-2424.
    PubMed    


  16. FISCHER J, Godecke A, Kelm M, Heusch G, et al
    Master switches in cardiac ischaemia: the Collaborative Research Center (CRC) 1116 of the German Research Foundation.
    Eur Heart J. 2022;43:2350-2351.
    PubMed    


    June 2022
  17. CREA F
    Antiplatelet treatment of acute coronary syndromes: novel clinical and translational perspectives.
    Eur Heart J. 2022;43:2253-2256.
    PubMed    


  18. ZHU H, Chen T, Huang J
    An attempt to better show some results such as the comparison of mortality and major adverse cardiovascular events between the abnormal and normal coronary flow reserve cohorts.
    Eur Heart J. 2022;43:2338-2339.
    PubMed    


  19. SCHIELE F, Meneveau N
    NSTEMI management: a fall from GRACE?
    Eur Heart J. 2022;43:2300-2302.
    PubMed    


  20. TAKEI Y, Abe N, Bohgaki M, Kasahara H, et al
    Paradoxical enlargement of immunoglobulin G4 (IgG4)-related coronary aneurysms despite controlling serum IgG4 level.
    Eur Heart J. 2022;43:2250.
    PubMed    


  21. CACHEUX M, Akar FG
    A novel exosome-based therapy for post-MI arrhythmias.
    Eur Heart J. 2022;43:2157-2159.
    PubMed    


    May 2022
  22. GANESANANTHAN S, Rajkumar CA, Foley M, Thompson D, et al
    Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
    Eur Heart J. 2022 May 26. pii: 6593472. doi: 10.1093.
    PubMed     Abstract available


  23. VAN VELDHUISEN SL, Gorter TM, van Woerden G, de Boer RA, et al
    Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1955-1969.
    PubMed     Abstract available


  24. VALGIMIGLI M, Smits PC, Frigoli E, Bongiovanni D, et al
    Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.
    Eur Heart J. 2022 May 17. pii: 6587125. doi: 10.1093.
    PubMed     Abstract available


  25. SPOSITO AC
    Soluble LOX-1 levels during acute coronary syndrome: a potent and multifaceted warning sign for cardiovascular risk.
    Eur Heart J. 2022;43:1861-1863.
    PubMed    


  26. KRALER S, Wenzl FA, Georgiopoulos G, Obeid S, et al
    Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes.
    Eur Heart J. 2022;43:1849-1860.
    PubMed     Abstract available


  27. WANG J, Chen H, Zhang L
    Coronary artery fistula bypassed the left main coronary artery blocked by a large cardiogenic thrombus.
    Eur Heart J. 2022;43:1885.
    PubMed    


  28. LU X, Liu Z, Cui Q, Liu F, et al
    A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.
    Eur Heart J. 2022;43:1702-1711.
    PubMed     Abstract available


  29. HAGEMAN SHJ, McKay AJ, Ueda P, Gunn LH, et al
    Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
    Eur Heart J. 2022;43:1715-1727.
    PubMed     Abstract available


  30. FRANTZ S, Hundertmark MJ, Schulz-Menger J, Bengel FM, et al
    Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.
    Eur Heart J. 2022 May 4. pii: 6578707. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  31. CREA F
    Inflammation, targeted proteomics, and microvascular dysfunction: the new frontiers of ischaemic heart disease.
    Eur Heart J. 2022;43:1517-1520.
    PubMed    


  32. STEFFENS S, Nahrendorf M, Madonna R
    Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies.
    Eur Heart J. 2022;43:1533-1541.
    PubMed     Abstract available


  33. KELSHIKER MA, Seligman H, Howard JP, Rahman H, et al
    Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1582-1593.
    PubMed     Abstract available


  34. MORICI N, De Servi S, De Luca L, Crimi G, et al
    Management of acute coronary syndromes in older adults.
    Eur Heart J. 2022;43:1542-1553.
    PubMed     Abstract available


  35. HONG S, Kim KS, Han K, Park CY, et al
    Acromegaly and cardiovascular outcomes: a cohort study.
    Eur Heart J. 2022;43:1491-1499.
    PubMed     Abstract available


  36. FERNANDEZ ASENSIO R, Pascual Calleja I, Moris de la Tassa C, Colunga Blanco S, et al
    Pneumopericardium mimicking ST-segment elevation acute coronary syndrome.
    Eur Heart J. 2022;43:1516.
    PubMed    


  37. SAMMONS E, Hopewell JC, Chen F, Stevens W, et al
    Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
    Eur Heart J. 2022;43:1416-1424.
    PubMed     Abstract available


  38. BATRA G, Aktaa S, Wallentin L, Maggioni AP, et al
    Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart).
    Eur Heart J. 2022 Apr 5. pii: 6563567. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  39. BUCCIARELLI-DUCCI C, Ajmone-Marsan N, Di Carli M, Nicol E, et al
    The year in cardiovascular medicine 2021: imaging.
    Eur Heart J. 2022;43:1288-1295.
    PubMed     Abstract available


  40. BYRNE RA, Rai H, Colleran R
    Amphilimus-eluting stents in coronary artery disease: finally, a sweet spot for patients with diabetes mellitus?
    Eur Heart J. 2022;43:1331-1333.
    PubMed    


  41. HAN Y
    Chinese expert consensus statement on dual antiplatelet therapy in patients with coronary artery disease.
    Eur Heart J. 2022;43:1283-1285.
    PubMed    


  42. ROMAGUERA R, Salinas P, Gomez-Lara J, Brugaletta S, et al
    Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.
    Eur Heart J. 2022;43:1320-1330.
    PubMed     Abstract available


  43. OKA S, Endo H, Takagi K, Yamagata K, et al
    Mechanical coronary artery stenosis induced by active fixation left ventricular lead: a case of acute complication after cardiac resynchronization therapy device implantation.
    Eur Heart J. 2022;43:1271.
    PubMed    


  44. THYGESEN K, Jaffe AS
    Revisiting the definition of perioperative myocardial infarction after coronary artery bypass grafting.
    Eur Heart J. 2022 Mar 17. pii: 6549761. doi: 10.1093.
    PubMed    


  45. HAN Y, Li Y
    Adherence to P2Y12 inhibitors in acute coronary syndrome after a percutaneous coronary intervention: what can we improve?
    Eur Heart J. 2022 Mar 17. pii: 6549760. doi: 10.1093.
    PubMed    


  46. TURGEON RD, Koshman SL, Dong Y, Graham MM, et al
    P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications.
    Eur Heart J. 2022 Mar 17. pii: 6549798. doi: 10.1093.
    PubMed     Abstract available


  47. TUAL-CHALOT S, Stellos K
    Chrono-pharmacology-based antiplatelet therapy for acute myocardial infarction.
    Eur Heart J. 2022 Mar 10. pii: 6546087. doi: 10.1093.
    PubMed    


  48. DAWKINS JF, Ehdaie A, Rogers R, Soetkamp D, et al
    Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy.
    Eur Heart J. 2022 Mar 9. pii: 6545456. doi: 10.1093.
    PubMed     Abstract available


  49. TAN S, White HD, Layland J
    Heparin use in acute coronary syndromes and cardiovascular interventions: habit or evidence based?
    Eur Heart J. 2022;43:1008-1011.
    PubMed    


  50. SILVAIN J, Hausenloy D, Zeitouni M
    Appropriate criteria for the definition of Type 4a MI.
    Eur Heart J. 2022;43:1013-1014.
    PubMed    


    February 2022
  51. MOLEDINA SM, Kontopantelis E, Wijeysundera HC, Banerjee S, et al
    Ethnicity-dependent performance of the Global Registry of Acute Coronary Events risk score for prediction of non-ST-segment elevation myocardial infarction in-hospital mortality: nationwide cohort study.
    Eur Heart J. 2022 Feb 24. pii: 6529720. doi: 10.1093.
    PubMed     Abstract available


  52. ZENG C, Rosenberg L, Li X, Djousse L, et al
    Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension.
    Eur Heart J. 2022 Feb 24. pii: 6535634. doi: 10.1093.
    PubMed     Abstract available


  53. PRICE S, Katz J, Kaufmann CC, Huber K, et al
    The year in cardiovascular medicine 2021: acute cardiovascular care and ischaemic heart disease.
    Eur Heart J. 2022;43:800-806.
    PubMed    


  54. SHRAUNER W, Lord EM, Nguyen XT, Song RJ, et al
    Frailty and cardiovascular mortality in more than 3 million US Veterans.
    Eur Heart J. 2022;43:818-826.
    PubMed     Abstract available


  55. VAROTTO L, De Boni A, Iannucci G, Caprioglio F, et al
    Uncommon intravascular lithotripsy for the treatment of subclavian steal syndrome: a case presenting with concomitant acute coronary syndrome and transient ischaemic attack.
    Eur Heart J. 2022;43:840.
    PubMed    


  56. LIUZZO G, Volpe M
    Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debate.
    Eur Heart J. 2022 Feb 21. pii: 6533241. doi: 10.1093.
    PubMed    


  57. OMRAN H, Deutsch MA, Groezinger E, Zittermann A, et al
    High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making.
    Eur Heart J. 2022 Feb 15. pii: 6528587. doi: 10.1093.
    PubMed     Abstract available


  58. LIUZZO G, Volpe M
    PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fraction.
    Eur Heart J. 2022;43:559-560.
    PubMed    


  59. POLZL L, Thielmann M, Cymorek S, Nagele F, et al
    Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis.
    Eur Heart J. 2022 Feb 9. pii: 6525341. doi: 10.1093.
    PubMed     Abstract available


  60. DE CATERINA R, Liga R, Boden WE
    Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence.
    Eur Heart J. 2022;43:387-390.
    PubMed    


    January 2022
  61. BRAUNWALD E
    How to live to 100 before developing clinical coronary artery disease: a suggestion.
    Eur Heart J. 2022;43:249-250.
    PubMed    


  62. SLIWICKA O, Damman P, Habets J
    Stress dynamic CT perfusion in the evaluation of acute coronary syndrome.
    Eur Heart J. 2022;43:244.
    PubMed    


  63. CREA F
    Hot topics in ischaemic heart disease: revascularization, hibernation, type 2 infarction, and proteomics.
    Eur Heart J. 2022;43:89-92.
    PubMed    


  64. NEWBY LK
    A new biomarker of acute coronary ischaemia: from bench to bedside?
    Eur Heart J. 2022;43:164-166.
    PubMed    


  65. RYAN M, Morgan H, Chiribiri A, Nagel E, et al
    Myocardial viability testing: all STICHed up, or about to be REVIVED?
    Eur Heart J. 2022;43:118-126.
    PubMed     Abstract available


  66. CUBEDO J, Padro T, Vilahur G, Crea F, et al
    Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events.
    Eur Heart J. 2022;43:153-163.
    PubMed     Abstract available


  67. QUADRI G, Tomassini F, Cerrato E, Varbella F, et al
    Emergency treatment of a giant coronary aneurysm: percutaneous intervention with coronary and peripheral tools.
    Eur Heart J. 2022;43:168.
    PubMed    


  68. DEMIR OM, Rahman H, van de Hoef TP, Escaned J, et al
    Invasive and non-invasive assessment of ischaemia in chronic coronary syndromes: translating pathophysiology to clinical practice.
    Eur Heart J. 2022;43:105-117.
    PubMed     Abstract available


    December 2021
  69. WANG R, Serruys PW, Gao C, Hara H, et al
    Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease.
    Eur Heart J. 2021;43:56-67.
    PubMed     Abstract available


  70. NICOLAS J, Giustino G, Dangas G
    Periprocedural myocardial infarction: multiple definitions and still a quest for consensus.
    Eur Heart J. 2021 Dec 21. pii: 6471447. doi: 10.1093.
    PubMed    


  71. LOZANO I, Vegas JM, Rondan J
    Percutaneous intervention in patients with cancer: can we offer an improvement in safety?
    Eur Heart J. 2021;42:4981.
    PubMed    


  72. WHITE HD, Schwartz GG, Szarek M, Bhatt DL, et al
    Alirocumab after acute coronary syndrome in patients with a history of heart failure.
    Eur Heart J. 2021 Dec 18. pii: 6469637. doi: 10.1093.
    PubMed     Abstract available


  73. GALLI M, Benenati S, Franchi F, Rollini F, et al
    Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
    Eur Heart J. 2021 Dec 16. pii: 6464193. doi: 10.1093.
    PubMed     Abstract available


  74. CREA F
    Percutaneous coronary interventions: more complex than fixing stenoses.
    Eur Heart J. 2021;42:4607-4611.
    PubMed    


  75. WHITE HD
    Cardiac death should be the primary endpoint for revascularization trials and meta-analyses.
    Eur Heart J. 2021;42:4697-4698.
    PubMed    


  76. AL-LAMEE R, Mintz GS
    What are the PROSPECTs and clinical implications of vulnerable plaque?
    Eur Heart J. 2021;42:4680-4682.
    PubMed    


  77. KEDHI E, Berta B, Roleder T, Hermanides RS, et al
    Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial.
    Eur Heart J. 2021;42:4671-4679.
    PubMed     Abstract available


    November 2021
  78. EGGERS KM, James SK, Lindahl B
    Myocardial infarction after elective percutaneous coronary intervention-which cardiac troponin cut-off to use?
    Eur Heart J. 2021 Nov 24. pii: 6438090. doi: 10.1093.
    PubMed    


  79. BOR WL, Ten Berg JM
    Known or new atrial fibrillation in patients with acute coronary syndrome: what's the difference?
    Eur Heart J. 2021;42:4562-4564.
    PubMed    


  80. DE SILVA R, Cheng K
    Microvascular angina: quo tendimus?
    Eur Heart J. 2021;42:4601-4604.
    PubMed    


  81. SHIMOKAWA H, Suda A, Takahashi J, Berry C, et al
    Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group.
    Eur Heart J. 2021;42:4592-4600.
    PubMed     Abstract available


  82. PITT B, Ferreira JP, Zannad F
    Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MI.
    Eur Heart J. 2021 Nov 12. pii: 6425576. doi: 10.1093.
    PubMed    


  83. CHIKWE J, Alfieri OR
    The optimal strategy for multivessel coronary revascularization.
    Eur Heart J. 2021 Nov 11. pii: 6425621. doi: 10.1093.
    PubMed    


  84. WINTHER S, Schmidt SE, Knuuti J, Bottcher M, et al
    Selecting the right cohorts and endpoints for the validation of pre-test probability models for obstructive coronary artery disease.
    Eur Heart J. 2021;42:4402-4403.
    PubMed    


  85. DERIMAY F, Finet G, Rioufol G
    Coronary artery stenosis prediction does not mean coronary artery stenosis obstruction.
    Eur Heart J. 2021;42:4401.
    PubMed    


  86. EGIDY ASSENZA G, Dimopoulos K, Budts W, Donti A, et al
    Management of acute cardiovascular complications in pregnancy.
    Eur Heart J. 2021;42:4224-4240.
    PubMed     Abstract available


    October 2021
  87. BIAN L, Fang Z, Qian H, Wu Z, et al
    Dumbbell on the heart: two giant left coronary artery aneurysms in an adolescent.
    Eur Heart J. 2021;42:4195.
    PubMed    


  88. AHN JM, Zimmermann FM, Arora S, Solberg OG, et al
    Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.
    Eur Heart J. 2021 Oct 19. pii: 6401958. doi: 10.1093.
    PubMed     Abstract available


  89. TSUDA K, Kanzaki Y, Hoshiga M
    Early cardiac magnetic resonance leads to diagnose the etiology of myocardial infarction with non-obstructive coronary arteries.
    Eur Heart J. 2021 Oct 18. pii: 6400298. doi: 10.1093.
    PubMed    


  90. WADSTROM BN, Wulff AB, Pedersen KM, Jensen GB, et al
    Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study.
    Eur Heart J. 2021 Oct 18. pii: 6399975. doi: 10.1093.
    PubMed     Abstract available


  91. LECHNER I, Reindl M, Tiller C, Holzknecht M, et al
    Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a cardiac magnetic resonance imaging study.
    Eur Heart J. 2021 Oct 11. pii: 6386704. doi: 10.1093.
    PubMed     Abstract available


  92. BANNING AP, Serruys P, De Maria GL, Ryan N, et al
    Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
    Eur Heart J. 2021 Oct 7. pii: 6383065. doi: 10.1093.
    PubMed     Abstract available


  93. CREA F
    The challenge of risk stratification in suspected angina, in myocardial infarction without risk factors, and in frail patients.
    Eur Heart J. 2021;42:3807-3811.
    PubMed    


  94. CURZEN N, Nicholas Z, Stuart B, Wilding S, et al
    Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial.
    Eur Heart J. 2021;42:3844-3852.
    PubMed     Abstract available


    September 2021
  95. HAN Y
    Long-term outcomes of new-generation coronary stents in China.
    Eur Heart J. 2021 Sep 18. pii: 6372216. doi: 10.1093.
    PubMed    


  96. GRINES CL, Mehta S
    ST-segment elevation myocardial infarction management: great strides but still room for improvement.
    Eur Heart J. 2021 Sep 16. pii: 6371299. doi: 10.1093.
    PubMed    


  97. SINHA A, Rahman H, Webb A, Shah AM, et al
    Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.
    Eur Heart J. 2021 Sep 16. pii: 6371296. doi: 10.1093.
    PubMed     Abstract available


  98. PETERS SAE, Kluin J
    Why do women do worse after coronary artery bypass grafting?
    Eur Heart J. 2021 Sep 15. pii: 6370651. doi: 10.1093.
    PubMed    


  99. JAFFER FA, Mehilli J, Escaned J
    Left main coronary disease at the bifurcation: should the pendulum swing back towards the provisional stenting approach?
    Eur Heart J. 2021 Sep 13. pii: 6368942. doi: 10.1093.
    PubMed    


  100. LOPEZ-SENDON JL, Cyr DD, Mark DB, Bangalore S, et al
    Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
    Eur Heart J. 2021 Sep 13. pii: 6368943. doi: 10.1093.
    PubMed     Abstract available


  101. BAYES-GENIS A, Diez J
    Transition to heart failure in hypertension: going to the heart of the matter.
    Eur Heart J. 2021 Sep 13. pii: 6369562. doi: 10.1093.
    PubMed    


  102. BROWN JM, Zhou W, Weber B, Divakaran S, et al
    Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease.
    Eur Heart J. 2021 Sep 7. pii: 6365821. doi: 10.1093.
    PubMed     Abstract available


  103. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
    Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
    Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
    PubMed     Abstract available


  104. MESSIKA-ZEITOUN D, Hibbert B, Chan V
    'Primary' percutaneous mitral valve repair in patients with acute myocardial infarction: is it ready for primetime?
    Eur Heart J. 2021 Sep 2. pii: 6362540. doi: 10.1093.
    PubMed    


    August 2021
  105. HABERMAN D, Estevez-Loureiro R, Benito-Gonzalez T, Denti P, et al
    Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction.
    Eur Heart J. 2021 Aug 31. pii: 6360026. doi: 10.1093.
    PubMed     Abstract available


  106. CREA F
    Pulmonary embolism, COVID, and bleeding risk in acute coronary syndromes: a Focus Issue on thrombosis and antithrombotic treatment.
    Eur Heart J. 2021;42:3109-3113.
    PubMed    


  107. YANG Q, Sun D, Pei C, Zeng Y, et al
    LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project.
    Eur Heart J. 2021;42:3175-3186.
    PubMed     Abstract available


  108. CERRATO E, Giacobbe F, Quadri G, Macaya F, et al
    Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry.
    Eur Heart J. 2021;42:3161-3171.
    PubMed     Abstract available


  109. WERESKI R, Kimenai DM, Bularga A, Taggart C, et al
    Risk factors for type 1 and type 2 myocardial infarction.
    Eur Heart J. 2021 Aug 25. pii: 6357312. doi: 10.1093.
    PubMed     Abstract available


  110. LUSEBRINK E, Massberg S, Orban M
    The lack of evidence-based therapeutic strategies for left ventricular unloading during venoarterial extracorporeal membrane oxygenation therapy calls for randomized trials.
    Eur Heart J. 2021;42:3105-3106.
    PubMed    


  111. KLOECKNER M, Guihaire J, Hascoet S
    Congestive pulmonary oedema during venoarterial extracorporeal membrane oxygenation support: a plea for balloon atrial septostomy.
    Eur Heart J. 2021;42:3103-3104.
    PubMed    


  112. DAVIERWALA PM, Gao C, Thuijs DJFM, Wang R, et al
    Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease.
    Eur Heart J. 2021 Aug 18. pii: 6354120. doi: 10.1093.
    PubMed     Abstract available


  113. BOSCH J, Lonn EM, Jung H, Zhu J, et al
    Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants.
    Eur Heart J. 2021;42:2995-3007.
    PubMed     Abstract available


  114. LEONE AM, Liuzzo G
    No blossom for fractional flow reserve in FLOWER-MI.
    Eur Heart J. 2021;42:2971-2972.
    PubMed    


  115. YANG H, Chang S, Qian J, Ge J, et al
    A gigantic coronary pseudoaneurysm in a 60-year-old man.
    Eur Heart J. 2021;42:3027.
    PubMed    


  116. ZEYMER U, Ludman P, Danchin N, Kala P, et al
    Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology.
    Eur Heart J. 2021 Aug 14. pii: 6352178. doi: 10.1093.
    PubMed     Abstract available


  117. WANG N, Sun Y, Zhang H, Wang B, et al
    Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease.
    Eur Heart J. 2021 Aug 10. pii: 6347324. doi: 10.1093.
    PubMed     Abstract available


  118. DE CATERINA R, Brown DL
    Interpreting myocardial infarction analyses in ISCHEMIA: separating facts from fallacy.
    Eur Heart J. 2021 Aug 5. pii: 6342393. doi: 10.1093.
    PubMed    


  119. GAUDINO M, Di Franco A, Alexander JH, Bakaeen F, et al
    Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data.
    Eur Heart J. 2021 Aug 2. pii: 6333765. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  120. KOSYAKOVSKY LB, Austin PC, Ross HJ, Wang X, et al
    Early invasive coronary angiography and acute ischaemic heart failure outcomes.
    Eur Heart J. 2021 Jul 30. pii: 6331345. doi: 10.1093.
    PubMed     Abstract available


  121. GOROG DA, Navarese EP, Andreotti F
    Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
    Eur Heart J. 2021 Jul 29. pii: 6330652. doi: 10.1093.
    PubMed    


  122. CREA F
    Addressing Residual Risk in Ischaemic Heart Disease with Anti-Inflammatory Drugs: Between Scylla and Charybdis.
    Eur Heart J. 2021;42:2715-2719.
    PubMed    


  123. WACKER J, Malaspinas I, Vallee JP, Beghetti M, et al
    Regression of coronary arteries aneurysms 6 months after multisystem inflammatory syndrome in children (MIS-C).
    Eur Heart J. 2021;42:2803.
    PubMed    


  124. ANSELMO A, Frank D, Papa L, Viviani Anselmi C, et al
    Myocardial hypoxic stress mediates functional cardiac extracellular vesicle release.
    Eur Heart J. 2021;42:2780-2792.
    PubMed     Abstract available


  125. STRANDBERG TE, Kovanen PT
    Coronary artery disease: 'gout' in the artery?
    Eur Heart J. 2021;42:2761-2764.
    PubMed    


  126. PRADHAN AD
    Time to commence or time out for colchicine in secondary prevention of cardiovascular disease?
    Eur Heart J. 2021;42:2776-2779.
    PubMed    


  127. ANGELINI F, Bocchino PP, Imazio M
    Colchicine and coronary artery disease: a virtuous adoption.
    Eur Heart J. 2021;42:2796-2797.
    PubMed    


  128. BOUABDALLAOUI N, Blondeau L, Tardif JC
    Lessons from COLCOT and LoDoCo2: colchicine for secondary prevention in coronary artery disease.
    Eur Heart J. 2021;42:2800-2801.
    PubMed    


  129. COLLISON D, Didagelos M, Aetesam-Ur-Rahman M, Copt S, et al
    Post-stenting fractional flow reserve vs coronary angiography for optimisation of percutaneous coronary intervention: TARGET-FFR trial.
    Eur Heart J. 2021 Jul 19. pii: 6323924. doi: 10.1093.
    PubMed     Abstract available


  130. MADHAVAN MV, Howard JP, Naqvi A, Ben-Yehuda O, et al
    Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials.
    Eur Heart J. 2021;42:2643-2654.
    PubMed     Abstract available


  131. ABDELWAHED YS, Schatz AS, Landmesser U, Skurk C, et al
    'Small bifurcation?' CT myocardial mass volume measurements change therapeutic strategy in coronary artery disease.
    Eur Heart J. 2021;42:2713-2714.
    PubMed    


  132. CREA F
    The growing complexity of the number one killer: ischaemic heart disease.
    Eur Heart J. 2021;42:2513-2517.
    PubMed    


  133. OIKONOMOU EK, Van Dijk D, Parise H, Suchard MA, et al
    A phenomapping-derived tool to personalize the selection of anatomical vs. functional testing in evaluating chest pain (ASSIST).
    Eur Heart J. 2021;42:2536-2548.
    PubMed     Abstract available


  134. COLLET JP, Thiele H
    Lesson learnt from the new 2020 ESC guidelines on non-ST-segment elevation acute coronary syndrome: when clinical judgement precedes and overpasses weak recommendations. 2020 non-ST-segment elevation acute coronary syndrome guidelines on pre-treatment
    Eur Heart J. 2021;42:2607-2608.
    PubMed    


  135. COLLET JP, Thiele H
    Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified?
    Eur Heart J. 2021;42:2611-2612.
    PubMed    


  136. SANNA GD
    Lesson learnt from the new 2020 ESC guidelines on NSTE-ACS: when clinical judgement precedes and overpasses weak recommendations.
    Eur Heart J. 2021;42:2605-2606.
    PubMed    


  137. KOW CS, Zaihan AF, Hasan SS
    Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified?
    Eur Heart J. 2021;42:2609-2610.
    PubMed    


  138. SHENOY S, Singh A, Acharya T
    Incidental isolated septal infarct in a young patient with colon cancer.
    Eur Heart J. 2021;42:2613.
    PubMed    



  139. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
    Eur Heart J. 2021;42:2455-2467.
    PubMed     Abstract available


  140. OZKAN J
    Patient Perspective: Maria George founder of INOCA International.
    Eur Heart J. 2021;42:2408-2410.
    PubMed    


    June 2021
  141. VOLPE M, Patrono C
    The increased mortality of STEMI patients without risk factors supports the need for evidence-based pharmacotherapy irrespective of perceived low risk.
    Eur Heart J. 2021;42:2329-2330.
    PubMed    


  142. CREA F
    The Universal Definition of Heart Failure, risk prediction in cardiogenic shock, artificial intelligence in cardiac allograft rejection, and the genetics of dilated cardiomyopathy.
    Eur Heart J. 2021;42:2317-2320.
    PubMed    


  143. HUBER K
    Scores for outcome prediction in patients admitted with cardiogenic shock.
    Eur Heart J. 2021;42:2353-2355.
    PubMed    


  144. LUSEBRINK E, Massberg S, Orban M
    The multiple options of left atrial and ventricular venting during veno-arterial extra-corporeal membrane oxygenation: practical considerations.
    Eur Heart J. 2021;42:2399-2400.
    PubMed    


  145. POZZI M, Grinberg D, Rioufol G
    Percutaneous left ventricular unloading in veno-arterial extracorporeal membrane oxygenation.
    Eur Heart J. 2021;42:2397-2398.
    PubMed    


  146. VOLPE M, Patrono C
    Vulnerable non-culprit coronary plaques: are they worth treating?
    Eur Heart J. 2021;42:2233-2234.
    PubMed    


  147. COLLET JP, Thiele H
    Major bleeding and the ADP-binding enzyme creatine kinase in non-ST-segment elevation acute coronary syndromes.
    Eur Heart J. 2021;42:2313-2314.
    PubMed    


  148. BREWSTER LM
    Because of its association with major bleeding the ADP-binding enzyme creatine kinase should be estimated in studies of patients treated for non-ST-segment elevation acute coronary syndromes (NSTE-ACS).
    Eur Heart J. 2021;42:2311-2312.
    PubMed    


    May 2021
  149. BULLUCK H, Paradies V, Barbato E, Baumbach A, et al
    Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardio
    Eur Heart J. 2021 May 31. pii: 6290281. doi: 10.1093.
    PubMed     Abstract available


  150. VARBO A, Nordestgaard BG
    Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction.
    Eur Heart J. 2021 May 23. pii: 6282433. doi: 10.1093.
    PubMed     Abstract available


  151. VAN DER STOUWE JG, Boeddinghaus J, Mueller C
    Long-term beta-blocker treatment in stable patients after myocardial infarction: a potential impact due to changes in the diagnosis of myocardial infarction?
    Eur Heart J. 2021 May 23. pii: 6282428. doi: 10.1093.
    PubMed    


  152. HOLT A, Blanche P, McGettigan P, Lamberts M, et al
    Temporal changes in myocardial infarction diagnostic criteria do not account for the lack of long-term beta-blocker effect on cardiovascular prognosis.
    Eur Heart J. 2021 May 23. pii: 6282429. doi: 10.1093.
    PubMed    



  153. Corrigendum to: Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomised trials.
    Eur Heart J. 2021 May 23. pii: 6282430. doi: 10.1093.
    PubMed    


  154. VOLZ S, Redfors B, Angeras O, Ioanes D, et al
    Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Eur Heart J. 2021 May 23. pii: 6282431. doi: 10.1093.
    PubMed     Abstract available


  155. NAVARESE EP, Lansky AJ, Kereiakes DJ, Kubica J, et al
    Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis.
    Eur Heart J. 2021 May 18. pii: 6276780. doi: 10.1093.
    PubMed     Abstract available


  156. HILDICK-SMITH D, Egred M, Banning A, Brunel P, et al
    The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN).
    Eur Heart J. 2021 May 18. pii: 6276782. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  157. JANSEN TPJ, Damman P, Nijveldt R
    Diagnostic necessity of cardiac MRI in myocardial infarction with no obstructive coronary arteries: an illustration.
    Eur Heart J. 2021 Apr 14. pii: 6225950. doi: 10.1093.
    PubMed    


  158. CREA F
    Guidelines on myocardial infarction, novel therapeutic targets in post-infarction remodelling, and a debate on the ISCHEMIA trial.
    Eur Heart J. 2021;42:1277-1280.
    PubMed    


  159. BODEN WE, Stone PH
    To stent or not to stent? Treating angina after ISCHEMIA-why a conservative approach with optimal medical therapy is the preferred initial management strategy for chronic coronary syndromes: insights from the ISCHEMIA trial.
    Eur Heart J. 2021;42:1394-1400.
    PubMed    


  160. GERSH BJ, Boden WE, Bhatt DL, Stone PH, et al
    To stent or not to stent? Treating angina after ISCHEMIA-introduction.
    Eur Heart J. 2021;42:1387-1388.
    PubMed    


  161. GERSH BJ, Bhatt DL
    To stent or not to stent? Treating angina after ISCHEMIA-the impact of the ISCHEMIA trial on the indications for angiography and revascularization in patients with stable coronary artery disease.
    Eur Heart J. 2021;42:1389-1393.
    PubMed    


  162. GAUDINO M, Di Franco A, Bhatt DL, Alexander JH, et al
    The association between coronary graft patency and clinical status in patients with coronary artery disease.
    Eur Heart J. 2021;42:1433-1441.
    PubMed     Abstract available


  163. RADICO F, Zimarino M, De Caterina R
    Is coronary flow velocity reserve just a marker of a higher atherosclerotic burden?
    Eur Heart J. 2021;42:1444-1445.
    PubMed    


  164. SCHRODER J, Prescott E
    Coronary flow velocity reserve adds prognostic information beyond presence or absence of non-obstructive coronary atherosclerosis.
    Eur Heart J. 2021;42:1442-1443.
    PubMed    


  165. SECHTEM U, Ong P
    Coronary stenoses in patients suspected to have obstructive coronary artery disease: the exemption rather than the rule!
    Eur Heart J. 2021;42:1412-1414.
    PubMed    


  166. WINTHER S, Schmidt SE, Rasmussen LD, Juarez Orozco LE, et al
    Validation of the European Society of Cardiology pre-test probability model for obstructive coronary artery disease.
    Eur Heart J. 2021;42:1401-1411.
    PubMed     Abstract available


  167. COLLET JP, Thiele H, Barbato E, Barthelemy O, et al
    2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
    Eur Heart J. 2021;42:1289-1367.
    PubMed    


  168. BARBATO E, Mehilli J, Sibbing D, Siontis GCM, et al
    Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients present
    Eur Heart J. 2021;42:1368-1378.
    PubMed    


  169. BARTHELEMY O, Jobs A, Meliga E, Mueller C, et al
    Questions and answers on workup diagnosis and risk stratification: a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
    Eur Heart J. 2021;42:1379-1386.
    PubMed    


  170. DING D, Huang J, Westra J, Cohen DJ, et al
    Immediate post-procedural functional assessment of percutaneous coronary intervention: current evidence and future directions.
    Eur Heart J. 2021 Apr 5. pii: 6211340. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  171. FRIGERIO M
    Fausto Rovelli (1918-2021): the father of Italian cardiology, pioneer of early reperfusion therapy for acute myocardial infarction, and unforgettable master for his hospital colleagues.
    Eur Heart J. 2021 Mar 29. pii: 6199127. doi: 10.1093.
    PubMed    


  172. FIOLET ATL, Opstal TSJ, Mosterd A, Eikelboom JW, et al
    Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
    Eur Heart J. 2021 Mar 26. pii: 6188997. doi: 10.1093.
    PubMed     Abstract available


  173. ZHANG H, Xiao Z, Yang P, Hu J, et al
    Ruptured coronary artery aneurysm mimicking as a giant mediastinal mass.
    Eur Heart J. 2021;42:1183.
    PubMed    


  174. KWOK CS, Wong CW, Kontopantelis E, Barac A, et al
    Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA.
    Eur Heart J. 2021;42:1019-1034.
    PubMed     Abstract available


  175. MARENZI G, Cosentino N, Cardinale D
    Ischaemic and bleeding risk in cancer patients undergoing PCI: another brick in the wall.
    Eur Heart J. 2021;42:1035-1037.
    PubMed    


  176. ERDMANN J, van der Laan SW
    Unfolding and disentangling coronary vascular disease through genome-wide association studies.
    Eur Heart J. 2021;42:934-937.
    PubMed    


  177. VAN DIEPEN S, Armstrong PW
    Learning whether to subtract beta-blockers: it's about time.
    Eur Heart J. 2021;42:915-918.
    PubMed     Abstract available


  178. IBANEZ B, Roque D, Price S
    The year in cardiovascular medicine 2020: acute coronary syndromes and intensive cardiac care.
    Eur Heart J. 2021;42:884-895.
    PubMed    


  179. WANG X, Yan C
    Progression of artery aneurysm after transcatheter closure of coronary artery fistula.
    Eur Heart J. 2021;42:918.
    PubMed    


    February 2021
  180. CEGLAREK U, Schellong P, Rosolowski M, Scholz M, et al
    The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction.
    Eur Heart J. 2021 Feb 27. pii: 6153946. doi: 10.1093.
    PubMed     Abstract available


  181. REFFO E, Stritoni V, Di Salvo G
    Inflammatory syndrome in children associated with COVID-19 complicated by acute myocardial infarction.
    Eur Heart J. 2021 Feb 20. pii: 6145783. doi: 10.1093.
    PubMed    


  182. BOUABDALLAOUI N, Tardif JC
    Initiation of low-dose colchicine early after myocardial infarction.
    Eur Heart J. 2021 Feb 4. pii: 6127594. doi: 10.1093.
    PubMed    


  183. HARTIALA JA, Han Y, Jia Q, Hilser JR, et al
    Genome-wide analysis identifies novel susceptibility loci for myocardial infarction.
    Eur Heart J. 2021 Feb 3. pii: 6126843. doi: 10.1093/eurheartj/ehaa1040.
    PubMed     Abstract available


  184. BERGONTI M
    Emergency Room visits in the COVID-19 pandemic.
    Eur Heart J. 2021;42:369-370.
    PubMed    


    January 2021
  185. XING Y, Dai N, Li H
    Is abnormal function with troponin T elevation definitely myocardial infarction?
    Eur Heart J. 2021 Jan 30. pii: 6124030. doi: 10.1093.
    PubMed    


  186. VAN DER SANGEN NMR, Rozemeijer R, Chan Pin Yin DRPP, Valgimigli M, et al
    Patient-tailored antithrombotic therapy following percutaneous coronary intervention.
    Eur Heart J. 2021 Jan 29. pii: 6122862. doi: 10.1093/eurheartj/ehaa1097.
    PubMed     Abstract available


  187. LUNARDI M, Onuma Y, Serruys PW
    Ticagrelor monotherapy following percutaneous coronary intervention for acute coronary syndrome in TWILIGHT patients: still a future for aspirin?
    Eur Heart J. 2021 Jan 27. pii: 6121205. doi: 10.1093.
    PubMed    


  188. VRACHATIS DA, Giannopoulos GV, Deftereos SG
    Colchicine administered early in acute myocardial infarction: ready, set ... go?
    Eur Heart J. 2021 Jan 22. pii: 6106966. doi: 10.1093.
    PubMed    



  189. Corrigendum to: Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.
    Eur Heart J. 2021;42:322.
    PubMed    


  190. JOBS A, Collet JP, Thiele H
    Optimal timing of invasive angiography in non-ST-segment elevation acute coronary syndromes-do we need more data?
    Eur Heart J. 2021;42:353-354.
    PubMed    


  191. KITE TA, Gershlick AH
    High-risk NSTE-ACS: high time for robust data.
    Eur Heart J. 2021;42:352.
    PubMed    


  192. SCHRODER J, Michelsen MM, Mygind ND, Suhrs HE, et al
    Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study.
    Eur Heart J. 2021;42:228-239.
    PubMed     Abstract available


  193. RAY KK
    Changing the paradigm for post-MI cholesterol lowering from intensive statin monotherapy towards intensive lipid-lowering regimens and individualized care.
    Eur Heart J. 2021;42:253-256.
    PubMed    


  194. DAVIES A, Fox K, Galassi AR, Banai S, et al
    Management of refractory angina: an update.
    Eur Heart J. 2021;42:269-283.
    PubMed     Abstract available


  195. SICARI R
    The curious incident of CFVR in clinical practice.
    Eur Heart J. 2021;42:240-242.
    PubMed    


  196. PLAT J, Strandberg TE, Gylling H
    Intestinal cholesterol and phytosterol absorption and the risk of coronary artery disease.
    Eur Heart J. 2021;42:281-282.
    PubMed    


  197. HELGADOTTIR A, Thorleifsson G, Stefansson K
    Increased absorption of phytosterols is the simplest and most plausible explanation for coronary artery disease risk not accounted for by non-HDL cholesterol in high cholesterol absorbers.
    Eur Heart J. 2021;42:283-284.
    PubMed    


  198. ABDELWAHED YS, Wurster TH, Landmesser U, Leistner DM, et al
    Culprit mistaken: development of a traumatic coronary aneurysm after mismatched culprit lesion-PCI for plaque rupture.
    Eur Heart J. 2021;42:287.
    PubMed    


  199. KOLBE M, Lopez-Ayala P, Mueller C
    Women who experience a myocardial infarction at a young age.
    Eur Heart J. 2021 Jan 19. pii: 6104220. doi: 10.1093.
    PubMed    


  200. CHATTOPADHYAY S, John J
    Women experiencing myocardial infarction at a young age have worse outcomes compared with men: only for non-cardiovascular deaths and when treated inadequately?
    Eur Heart J. 2021 Jan 17. pii: 6103003. doi: 10.1093.
    PubMed    


  201. HOLT A, Blanche P, Zareini B, Rajan D, et al
    Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish, nationwide cohort study.
    Eur Heart J. 2021 Jan 11. pii: 6082772. doi: 10.1093/eurheartj/ehaa1058.
    PubMed     Abstract available


  202. MONACO C, Cole J
    Does a myocardial infarction boost your (B cell) memory?
    Eur Heart J. 2021 Jan 4. pii: 6061967. doi: 10.1093/eurheartj/ehaa1059.
    PubMed    


  203. LIN S, Chen S, Zhe Z
    Model assessment: new measures should be known and traditional measures should be accurately interpreted.
    Eur Heart J. 2021;42:134-135.
    PubMed    


  204. AMINORROAYA A, Tajdini M, Masoudkabir F
    Time for clinicians to revisit their perspectives on C-statistic.
    Eur Heart J. 2021;42:132-133.
    PubMed    


  205. LAWLER PR, Bhatt DL, Godoy LC, Luscher TF, et al
    Targeting cardiovascular inflammation: next steps in clinical translation.
    Eur Heart J. 2021;42:113-131.
    PubMed     Abstract available


    December 2020
  206. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
    Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
    Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
    PubMed     Abstract available


  207. SCHUBERT J, Lindahl B, Melhus H, Renlund H, et al
    Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study.
    Eur Heart J. 2020 Dec 24. pii: 6047259. doi: 10.1093/eurheartj/ehaa1011.
    PubMed     Abstract available


  208. FIOLET ATL, Nidorf SM, Cornel JH
    Colchicine for secondary prevention in coronary disease.
    Eur Heart J. 2020 Dec 21. pii: 6042608. doi: 10.1093.
    PubMed    


  209. KYAW T, Loveland P, Kanellakis P, Cao A, et al
    Alarmin-activated B cells accelerate murine atherosclerosis after myocardial infarction via plasma cell-immunoglobulin-dependent mechanisms.
    Eur Heart J. 2020 Dec 18. pii: 6041767. doi: 10.1093.
    PubMed     Abstract available


  210. KOTANIDIS CP, Antoniades C
    Selfies in cardiovascular medicine: welcome to a new era of medical diagnostics.
    Eur Heart J. 2020;41:4412-4414.
    PubMed    


  211. ROY R, Koch WJ
    Adding another GRK to the fire of heart failure.
    Eur Heart J. 2020 Dec 7. pii: 6025474. doi: 10.1093.
    PubMed    


  212. LI L, Fu W, Gong X, Chen Z, et al
    The role of G protein-coupled receptor kinase 4 in cardiomyocyte injury after myocardial infarction.
    Eur Heart J. 2020 Dec 6. pii: 6024960. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  213. SILVAIN J, Zeitouni M, Paradies V, Zheng HL, et al
    Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data.
    Eur Heart J. 2020 Nov 30. pii: 6012927. doi: 10.1093.
    PubMed     Abstract available


  214. ORWAT S, Diller GP
    Congenital heart defects as an intrinsic additional risk factor for the occurrence and outcome of myocardial infarction.
    Eur Heart J. 2020 Nov 22. pii: 5998317. doi: 10.1093.
    PubMed    


  215. FEDCHENKO M, Mandalenakis Z, Giang KW, Rosengren A, et al
    Long-term outcomes after myocardial infarction in middle-aged and older patients with congenital heart disease-a nationwide study.
    Eur Heart J. 2020 Nov 21. pii: 5997447. doi: 10.1093.
    PubMed     Abstract available


  216. MUNZEL T, Hahad O, Daiber A
    The dark side of nocturnal light pollution. Outdoor light at night increases risk of coronary heart disease.
    Eur Heart J. 2020 Nov 21. pii: 5998262. doi: 10.1093.
    PubMed    


  217. BOHM M, Mahfoud F
    J-curve revisited.
    Eur Heart J. 2020;41:4283.
    PubMed    


  218. LIEW CH, McEvoy JW
    The diastolic blood pressure J-curve remains an observational research phenomenon that has not yet been proven as causal and should not be used to make invasive treatment decisions.
    Eur Heart J. 2020;41:4284-4285.
    PubMed    


  219. SUN S, Cao W, Ge Y, Ran J, et al
    Outdoor light at night and risk of coronary heart disease among older adults: a prospective cohort study.
    Eur Heart J. 2020 Nov 17. pii: 5986682. doi: 10.1093.
    PubMed     Abstract available


  220. ARSENOS P, Antoniou CK, Gatzoulis KA
    Risk stratification refinement and implantable cardioverter defibrillator protection for the coronary artery disease patients with a preserved left ventricular systolic function with a two-step programmed ventricular stimulation-inclusive approach.
    Eur Heart J. 2020 Nov 16. pii: 5983737. doi: 10.1093.
    PubMed    


  221. NEUVILLERS L, Veugeois A, Didier J, Paul JF, et al
    Myocardial infarction with non-obstructive coronary artery revealing a heart tumour.
    Eur Heart J. 2020 Nov 13. pii: 5981589. doi: 10.1093.
    PubMed    


  222. COLLET JP, Thiele H
    Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
    Eur Heart J. 2020 Nov 13. pii: 5981490. doi: 10.1093.
    PubMed    


  223. NICHOLLS M
    Australia and colchicine for coronary heart disease.
    Eur Heart J. 2020 Nov 10. pii: 5961660. doi: 10.1093.
    PubMed    


  224. VERDECCHIA P, Angeli F, Cavallini C
    Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
    Eur Heart J. 2020 Nov 9. pii: 5964168. doi: 10.1093.
    PubMed    


  225. LUSCHER TF
    The sooner, the better: anti-inflammation in acute myocardial infarction.
    Eur Heart J. 2020;41:4100-4102.
    PubMed    


  226. VRACHATIS DA, Deftereos S, Stefanini GG
    STEMI in COVID-19 patients: thrombolysis-first approach could yield more risk than benefit.
    Eur Heart J. 2020;41:4141-4142.
    PubMed    


  227. ZHANG L, Fan Y, Lu Z
    Compromised STEMI reperfusion strategy in the era of COVID-19 pandemic: pros and cons.
    Eur Heart J. 2020;41:4143.
    PubMed    


  228. CANNON CP
    Chronic kidney disease: a high-risk group that deserves intensive lipid lowering.
    Eur Heart J. 2020;41:4124-4126.
    PubMed    


  229. MELE M, Casavecchia G, Ieva R, Brunetti ND, et al
    Diagnosis of acute myocardial infarction in the time of the COVID-19 pandemic.
    Eur Heart J. 2020 Nov 4. pii: 5956256. doi: 10.1093.
    PubMed    


    October 2020
  230. BATKAI S, Genschel C, Viereck J, Rump S, et al
    CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure.
    Eur Heart J. 2020 Oct 22. pii: 5934677. doi: 10.1093.
    PubMed     Abstract available


  231. LANDMESSER U, Luscher TF
    Advancing RNA-targeted therapy for personalised prevention of coronary disease: focus on ANGPLT3.
    Eur Heart J. 2020;41:3946-3948.
    PubMed    


  232. TOKGOZOGLU L, Catapano AL
    Can EPA evaporate plaques?
    Eur Heart J. 2020;41:3933-3935.
    PubMed    


  233. BALLANTYNE CM, Virani SS
    Real-world data, theoretical application of guidelines, cost, and access: how do we optimize non-statin therapy for LDL-C/non-HDL-C/ApoB?
    Eur Heart J. 2020;41:3910-3912.
    PubMed    


  234. CHANDRASEKAR B, Alanbaei M
    Intracoronary imaging identifies plaque rupture underlying left main thrombosis in acute myocardial infarction without angiographically evident atherosclerosis.
    Eur Heart J. 2020 Oct 14. pii: 5922862. doi: 10.1093.
    PubMed    


  235. BONNET M, Champagnac A, Lantelme P, Harbaoui B, et al
    Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2.
    Eur Heart J. 2020;41:3863-3864.
    PubMed    


  236. TWEET MS
    Sex differences among young individuals with myocardial infarction.
    Eur Heart J. 2020 Oct 13. pii: 5921646. doi: 10.1093.
    PubMed    


  237. DEFILIPPIS EM, Collins BL, Singh A, Biery DW, et al
    Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registry.
    Eur Heart J. 2020 Oct 13. pii: 5921645. doi: 10.1093.
    PubMed     Abstract available


  238. LIUZZO G, Patrono C
    Low-dose colchicine: a new tool in the treatment of chronic coronary disease? Comment on the low-dose colchicine (LoDoCo)2 trial.
    Eur Heart J. 2020 Oct 7. pii: 5918829. doi: 10.1093.
    PubMed    


  239. BOLLI R
    Cell therapy for acute myocardial infarction: Requiescat in Pace.
    Eur Heart J. 2020;41:3711-3714.
    PubMed    


  240. LANSKY A, Grubman D, Scheller B
    Paclitaxel-coated balloons: a safe alternative to drug-eluting stents for coronary in-stent restenosis.
    Eur Heart J. 2020;41:3729-3731.
    PubMed    


  241. STOREY RF
    The long journey of individualizing antiplatelet therapy after acute coronary syndromes.
    Eur Heart J. 2020;41:3546-3548.
    PubMed    


  242. LIUZZO G, Pedicino D, Vinci R, Crea F, et al
    CD8 lymphocytes and plaque erosion: a new piece in the jigsaw.
    Eur Heart J. 2020;41:3561-3563.
    PubMed    


  243. BABER U, Dangas G, Angiolillo DJ, Cohen DJ, et al
    Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.
    Eur Heart J. 2020;41:3533-3545.
    PubMed     Abstract available


    September 2020
  244. PARODI G, Sanna GD, Saba PS
    Understanding the complex interplay between coronary artery disease and Takotsubo syndrome: not all swans are white.
    Eur Heart J. 2020;41:3268-3270.
    PubMed    


  245. WALTERSCHEID B, Nguyen J, Tarbox M, Eshak N, et al
    Clopidogrel-induced sweet syndrome: severe dermatological complication after percutaneous coronary intervention.
    Eur Heart J. 2020 Sep 4. pii: 5901663. doi: 10.1093.
    PubMed    


  246. LIBERALE L, Gorog DA
    Low-grade endotoxaemia and platelets: a deadly aggregation.
    Eur Heart J. 2020;41:3166-3168.
    PubMed    


  247. SCHUPKE S, Kastrati A
    Mechanistic insights into the superior clinical efficacy of prasugrel over ticagrelor.
    Eur Heart J. 2020;41:3153-3155.
    PubMed    


    August 2020
  248. VRANCKX P, Valgimigli M, Eckardt L, Lewalter T, et al
    Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.
    Eur Heart J. 2020 Aug 29. pii: 5898835. doi: 10.1093.
    PubMed     Abstract available


  249. TUNON J, Steg PG, Bhatt DL, Bittner VA, et al
    Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.
    Eur Heart J. 2020 Aug 21. pii: 5895197. doi: 10.1093.
    PubMed     Abstract available


  250. KHAN S
    Mast cell tryptase level should be checked in all patients with suspected Kounis syndrome.
    Eur Heart J. 2020;41:3018.
    PubMed    


  251. CHATTERJEE NA, Tikkanen JT, Albert CM
    The electrocardiogram and sudden death: capturing electrical physiology and arrhythmic substrate.
    Eur Heart J. 2020;41:2911-2912.
    PubMed    


  252. ASATRYAN B, Roten L, Reichlin T
    Identifying coronary artery disease patients at risk for sudden and/or arrhythmic death: remaining limitations of the electrocardiogram.
    Eur Heart J. 2020;41:2911-2912.
    PubMed    


    July 2020
  253. WEINGARTNER O, Patel SB, Lutjohann D
    It's time to personalize and optimize lipid-lowering therapy.
    Eur Heart J. 2020;41:2629-2631.
    PubMed    


  254. HOWARD JP, Arnold AD, Ahmad Y
    Bias, heterogeneity, and uncertainty in meta-analysis.
    Eur Heart J. 2020;41:2712.
    PubMed    


  255. LI Y, Yan L, Shui S, Han X, et al
    Choriocarcinoma metastasis in the left atrium.
    Eur Heart J. 2020;41:2628.
    PubMed    


  256. TAN HL, van Dongen LH, Zimmerman DS
    Sudden cardiac death in young patients with diabetes: a call to study additional causes beyond ischaemic heart disease.
    Eur Heart J. 2020;41:2707-2709.
    PubMed    


  257. TU S, Westra J, Adjedj J, Wijns W, et al
    Physiological assessment of non-culprit stenoses during acute coronary syndromes.
    Eur Heart J. 2020;41:2598.
    PubMed    


  258. WACKER J, Malaspinas I, Aggoun Y, Bordessoule A, et al
    Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology.
    Eur Heart J. 2020;41:3103.
    PubMed    


    June 2020
  259. JAYARAJ R, Kumaraswamy C, Shaw P
    Clinical and conceptual approaches to interpreting the findings of systematic review and meta-analysis of mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease.
    Eur Heart J. 2020 Jun 26. pii: 5863013. doi: 10.1093.
    PubMed    


  260. STIEKEMA LCA, Hovingh GK, Stroes ESG
    The therapeutic age paradox coming to an end.
    Eur Heart J. 2020;41:2259-2261.
    PubMed    


  261. PAVASINI R, D'Ascenzo F, Campo G
    Moving forward from statistical to clinical considerations regarding complete revascularization.
    Eur Heart J. 2020;41:2225.
    PubMed    


  262. JOBS A, Schwarzer G, Thiele H
    Conclusions of complete revascularization meta-analysis are challenged by state-of-the-art methods.
    Eur Heart J. 2020;41:2223-2224.
    PubMed    


  263. THYGESEN K, Jaffe AS
    Our nearly complete diagnostic trip of thousands of steps begets a new trip therapeutically.
    Eur Heart J. 2020;41:2217-2219.
    PubMed    


  264. KONDAPALLI L, Moslehi J, Bonaca MP
    Inflammation begets inflammation: cancer and acute MI.
    Eur Heart J. 2020;41:2194-2196.
    PubMed    


  265. DUSI V, De Ferrari GM, Schwartz PJ
    There are 100 ways by which the sympathetic nervous system can trigger life-threatening arrhythmias.
    Eur Heart J. 2020;41:2180-2182.
    PubMed    


  266. OLSHANSKY B
    The electrocardiogram: are we at the dawn of a new era?
    Eur Heart J. 2020;41:2000-2002.
    PubMed    


    May 2020
  267. BJORNSTAD JL, Bendz B
    Periprocedural myocardial injury in the EXCEL trial.
    Eur Heart J. 2020;41:1703.
    PubMed    


  268. HESS CN, Hiatt WR
    Progress in the prevention and treatment of atherosclerotic cardiovascular disease: two steps forward, one step back.
    Eur Heart J. 2020;41:1650-1652.
    PubMed    


    April 2020
  269. LUSCHER TF
    Sex and gender and cardiovascular medicine: impact in diabetes, acute coronary syndromes, and heart failure.
    Eur Heart J. 2020;41:1311-1314.
    PubMed    


    March 2020
  270. MESSERLI FH, Bangalore S, Messerli AW, Raber L, et al
    The muddy waters of the J-curve and coronary revascularization.
    Eur Heart J. 2020 Mar 2. pii: 5771269. doi: 10.1093.
    PubMed    


  271. KIM WC, Sumaya W, Elkhateeb OE
    Fibroelastoma presenting with recurrent myocardial infarction and diagnosed with intracoronary imaging: a novel intracoronary image of fibroelastoma.
    Eur Heart J. 2020 Mar 2. pii: 6157022. doi: 10.1093.
    PubMed    


  272. AHMAD Y, Howard JP, Arnold AD, Cook CM, et al
    Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2020 Mar 2. pii: 5771278. doi: 10.1093.
    PubMed     Abstract available


  273. KLEBER ME, Delgado GE, Marz W
    LDL receptor traffic: in the fast lane.
    Eur Heart J. 2020;41:1054-1056.
    PubMed    


    February 2020
  274. LABRECQUE JA, Kaufman JS, Huang JY
    Genetic instruments with too many strings: acknowledging pleiotropy and population structure in Mendelian randomization studies.
    Eur Heart J. 2020;41:892-893.
    PubMed    


  275. SINNAEVE P, Van de Werf F
    Primary PCI and the indistinct 120 min time limit.
    Eur Heart J. 2020;41:867-869.
    PubMed    


  276. GIANNOPOULOS AA, Gaemperli O
    The power of myocardial blood flow reserve in personalizing management of patients with stable coronary artery disease. Is it time to move on from percentage of ischaemia?
    Eur Heart J. 2020;41:769-771.
    PubMed    


    January 2020
  277. LUSCHER TF
    Chronic coronary syndromes: expanding the spectrum and natural history of ischaemic heart disease.
    Eur Heart J. 2020;41:333-336.
    PubMed    


  278. IANNACCONE M, Brilakis ES, Boccuzzi GG
    An App for complex PCI solutions.
    Eur Heart J. 2020;41:342-344.
    PubMed    


  279. AL'AREF SJ, Maliakal G, Singh G, van Rosendael AR, et al
    Machine learning of clinical variables and coronary artery calcium scoring for the prediction of obstructive coronary artery disease on coronary computed tomography angiography: analysis from the CONFIRM registry.
    Eur Heart J. 2020;41:359-367.
    PubMed     Abstract available


  280. KNUUTI J, Wijns W, Saraste A, Capodanno D, et al
    2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
    Eur Heart J. 2020;41:407-477.
    PubMed    


  281. SORBETS E, Fox KM, Elbez Y, Danchin N, et al
    Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry.
    Eur Heart J. 2020;41:347-356.
    PubMed     Abstract available


  282. PRATI F, Romagnoli E, Gatto L, La Manna A, et al
    Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study.
    Eur Heart J. 2020;41:383-391.
    PubMed     Abstract available


  283. HILVO M, Meikle PJ, Pedersen ER, Tell GS, et al
    Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.
    Eur Heart J. 2020;41:371-380.
    PubMed     Abstract available


  284. ALI ZA, McEntegart M, Hill JM, Spratt JC, et al
    Intravascular lithotripsy for treatment of stent underexpansion secondary to severe coronary calcification.
    Eur Heart J. 2020;41:485-486.
    PubMed    


  285. LEE HS, Chang M, Piccinelli M, Koo BK, et al
    Complete regression of coronary atherosclerosis.
    Eur Heart J. 2020;41:332.
    PubMed    


  286. BAUMBACH A, Bourantas CV, Serruys PW, Wijns W, et al
    The year in cardiology: coronary interventions.
    Eur Heart J. 2020 Jan 6. pii: 5694318. doi: 10.1093.
    PubMed    


  287. SCHNORBUS B, Daiber A, Jurk K, Warnke S, et al
    Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel study.
    Eur Heart J. 2020 Jan 3. pii: 5695774. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  288. KOGAME N, Serruys PW, Onuma Y
    Cracking (the code of) coronary artery calcification to win the last battle of percutaneous coronary intervention: still in the middle of a rocky road.
    Eur Heart J. 2019 Dec 23. pii: 5686015. doi: 10.1093.
    PubMed    


  289. MALMBORG M, Schmiegelow MDS, Norgaard CH, Munch A, et al
    Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?
    Eur Heart J. 2019 Dec 20. pii: 5682397. doi: 10.1093.
    PubMed     Abstract available


  290. LOPEZ-JIMENEZ F, Gersh BJ
    Secondary prevention after coronary artery bypass grafting saves lives: a golden opportunity often wasted.
    Eur Heart J. 2019 Dec 4. pii: 5651910. doi: 10.1093.
    PubMed    


    November 2019
  291. EBERHARD M, Hermann M, Stahli BE, Manka R, et al
    Amphetamine-induced coronary artery dissection and massive aortic valve thrombus.
    Eur Heart J. 2019 Nov 25. pii: 5640488. doi: 10.1093.
    PubMed    


  292. LUSCHER TF
    Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes.
    Eur Heart J. 2019;40:3579-3582.
    PubMed    


  293. SINNAEVE PR, Schwartz GG, Wojdyla DM, Alings M, et al
    Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.
    Eur Heart J. 2019 Nov 16. pii: 5626150. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  294. GARGIULO G, Goette A, Tijssen J, Eckardt L, et al
    Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based rand
    Eur Heart J. 2019 Oct 25. pii: 5607287. doi: 10.1093.
    PubMed     Abstract available


  295. BJORKLUND E, Nielsen SJ, Hansson EC, Karlsson M, et al
    Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry.
    Eur Heart J. 2019 Oct 22. pii: 5602556. doi: 10.1093.
    PubMed     Abstract available


  296. IBANEZ B
    And fibrinolysis became pharmacoinvasive.
    Eur Heart J. 2019 Oct 12. pii: 5586502. doi: 10.1093.
    PubMed    


    August 2019
  297. TAYAL B, Fruelund P, Sogaard P, Riahi S, et al
    Incidence of heart failure after pacemaker implantation: a nationwide Danish Registry-based follow-up study.
    Eur Heart J. 2019 Aug 26. pii: 5554632. doi: 10.1093.
    PubMed     Abstract available


  298. LUSCHER TF
    Refining percutaneous coronary intervention: intracoronary imaging, haemodynamics, P2Y12 antagonists, and public outcomes reporting.
    Eur Heart J. 2019;40:2549-2552.
    PubMed    


  299. SERRUYS PW, Takahashi K, Chichareon P, Kogame N, et al
    Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
    Eur Heart J. 2019;40:2595-2604.
    PubMed     Abstract available


    June 2019
  300. MEHRA MR, Vaduganathan M, Fu M, Ferreira JP, et al
    A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial
    Eur Heart J. 2019 Jun 25. pii: 5522950. doi: 10.1093.
    PubMed     Abstract available


  301. CONEN D, Alonso-Coello P, Douketis J, Chan MTV, et al
    Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery.
    Eur Heart J. 2019 Jun 25. pii: 5523034. doi: 10.1093.
    PubMed     Abstract available


  302. PIAZZA G, Hurwitz S, Galvin CE, Harrigan L, et al
    Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT).
    Eur Heart J. 2019 Jun 22. pii: 5521151. doi: 10.1093.
    PubMed     Abstract available


  303. GENTILLE LORENTE DI
    Coconut atrium: a rare entity to cause pulmonary hypertension.
    Eur Heart J. 2019 Jun 4. pii: 5510776. doi: 10.1093.
    PubMed    


    May 2019
  304. URBAN P, Mehran R, Colleran R, Angiolillo DJ, et al
    Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
    Eur Heart J. 2019 May 22. pii: 5492739. doi: 10.1093.
    PubMed     Abstract available


  305. DEVEREAUX PJ, Szczeklik W
    Myocardial injury after non-cardiac surgery: diagnosis and management.
    Eur Heart J. 2019 May 16. pii: 5490290. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  306. JONES DA, Rathod KS, Koganti S, Lim P, et al
    The association between the public reporting of individual operator outcomes with patient profiles, procedural management, and mortality after percutaneous coronary intervention: an observational study from the Pan-London PCI (BCIS) Registry using an
    Eur Heart J. 2019 Apr 10. pii: 5443278. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  307. GRABHER F, Hamm W, Massberg S, Orban M, et al
    Uncommon cause of progressive dyspnoea 12 years after coronary artery bypass surgery.
    Eur Heart J. 2019 Mar 12. pii: 5377349. doi: 10.1093.
    PubMed    


    January 2019
  308. KHAN AA, Lip GYH
    Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?
    Eur Heart J. 2019 Jan 21. pii: 5298544. doi: 10.1093.
    PubMed    


    November 2018
  309. POTTS JE, Iliescu CA, Lopez Mattei JC, Martinez SC, et al
    Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States.
    Eur Heart J. 2018 Nov 30. pii: 5221009. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: